Crohn's disease
G Roda, S Chien Ng, PG Kotze, M Argollo… - Nature Reviews …, 2020 - nature.com
Crohn's disease is an inflammatory bowel disease that is characterized by chronic
inflammation of any part of the gastrointestinal tract, has a progressive and destructive …
inflammation of any part of the gastrointestinal tract, has a progressive and destructive …
Management of Crohn disease: a review
K Cushing, PDR Higgins - Jama, 2021 - jamanetwork.com
Importance Crohn disease, a chronic gastrointestinal inflammatory disease, is increasing in
incidence and prevalence in many parts of the world. Uncontrolled inflammation leads to …
incidence and prevalence in many parts of the world. Uncontrolled inflammation leads to …
ACG clinical guideline: management of Crohn's disease in adults
GR Lichtenstein, EV Loftus, KL Isaacs… - Official journal of the …, 2018 - journals.lww.com
Crohn's disease is an idiopathic inflammatory disorder of unknown etiology with genetic,
immunologic, and environmental influences. The incidence of Crohn's disease has steadily …
immunologic, and environmental influences. The incidence of Crohn's disease has steadily …
ECCO guidelines on therapeutics in Crohn's disease: medical treatment
2. Methods Based on the GRADE workflow, the Guidelines Committee of ECCO [GuiCom]
selected a panel of 48 experts supported by a team of methodologists and librarians …
selected a panel of 48 experts supported by a team of methodologists and librarians …
Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial
JF Colombel, R Panaccione, P Bossuyt, M Lukas… - The Lancet, 2017 - thelancet.com
Background Biomarkers of intestinal inflammation, such as faecal calprotectin and C-
reactive protein, have been recommended for monitoring patients with Crohn's disease, but …
reactive protein, have been recommended for monitoring patients with Crohn's disease, but …
Approach to the management of recently diagnosed inflammatory bowel disease patients: a user's guide for adult and pediatric gastroenterologists
Inflammatory bowel diseases (IBDs), including Crohn's disease and ulcerative colitis, are
chronic, progressive, immune-mediated diseases of adults and children that have no cure …
chronic, progressive, immune-mediated diseases of adults and children that have no cure …
ECCO guidelines on therapeutics in Crohn's disease: surgical treatment
M Adamina, S Bonovas, T Raine… - Journal of Crohn's …, 2020 - academic.oup.com
This article is the second in a series of two publications relating to the European Crohn's and
Colitis Organisation [ECCO] evidence-based consensus on the management of Crohn's …
Colitis Organisation [ECCO] evidence-based consensus on the management of Crohn's …
Mechanisms, management, and treatment of fibrosis in patients with inflammatory bowel diseases
F Rieder, C Fiocchi, G Rogler - Gastroenterology, 2017 - Elsevier
In the last 10 years, we have learned much about the pathogenesis, diagnosis, and
management of intestinal fibrosis in patients with inflammatory bowel diseases. Just a …
management of intestinal fibrosis in patients with inflammatory bowel diseases. Just a …
Crohn's disease
J Torres, S Mehandru, JF Colombel, L Peyrin-Biroulet - The Lancet, 2017 - thelancet.com
Crohn's disease is a chronic inflammatory disease of the gastrointestinal tract, with
increasing incidence worldwide. Crohn's disease might result from a complex interplay …
increasing incidence worldwide. Crohn's disease might result from a complex interplay …
The epidemiology of inflammatory bowel disease
J Burisch, P Munkholm - Scandinavian journal of gastroenterology, 2015 - Taylor & Francis
Background and aims. The inflammatory bowel diseases (IBD), Crohn's disease (CD) and
ulcerative colitis (UC), are chronic relapsing disorders of unknown aetiology. The aim of this …
ulcerative colitis (UC), are chronic relapsing disorders of unknown aetiology. The aim of this …